FDA Approved: TUKYSA — Supplemental Application (SEAGEN INC.)

View source ↗

Summary

FDA approved a supplemental application for TUKYSA (tucatinib) from Seagen, resulting in an updated label/indication for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tukysa (tucatinib)

Snippet

SUPPL AP for TUKYSA (TUCATINIB)